Sign in

Ross Cheloha

@rche54.bsky.social
636 followers 704 following 74 posts

Investigator studying Chemical Biology of Signalling. Science, junk food, and Nebraska athletics enthusiast. Posts-my own and not my employer's scholar.google.com/citations?user=Q…

PostsRepliesMedia
Ross Cheloha @rche54.bsky.social · 25/09/2026
Germicidal
020
Ross Cheloha @rche54.bsky.social · 29/08/2026
St Denis Medical - a fun comedy!
011
Ross Cheloha @rche54.bsky.social · 07/08/2026
John was such an encouraging and thoughtful presence within the NIH IRP. I will dearly miss seeing him in the halls and talking science and/or life. A huge loss
011
Reposted by Ross Cheloha
Retro Tech Dreams @retrotechdreams.bsky.social · 14/04/2026
Myst (1993)
1344482
Ross Cheloha @rche54.bsky.social · 03/02/2026
Gotta believe in your product!
000
Ross Cheloha @rche54.bsky.social · 27/01/2026
Congrats to Shubhra Jyoti Saha on leading this very successful project in the lab, and our collaborators for making this work possible. Many thanks to NIH Office of AIDS Research and the NIH IRP (NIDDK and NIAID) for supporting this work.
000
Ross Cheloha @rche54.bsky.social · 27/01/2026
They also retain strong activity against every strain of HIV tested. Such conjugates are even more potent than monoclonal antibodies and fusion inhibitor peptides applied in the clinic.
100
Ross Cheloha @rche54.bsky.social · 27/01/2026
This was a collaboration with the Bewley and Doria-Rose labs at NIH IRP. Linking fusion inhibitor peptides, which block HIV viral infection with modest potency, to single domain antibodies for delivery to the cell surface, leads to enormous enhancements in antiviral potency (up to 10,000-fold!)
100
Ross Cheloha @rche54.bsky.social · 27/01/2026
My first corresponding author publication in @jacs.acspublications.org Very proud and feeling like a bona fide chemist pubs.acs.org/doi/full/10....
pubs.acs.org
270
Reposted by Ross Cheloha
Janelia Research Campus @hhmijanelia.bsky.social · 15/12/2025
Apply by Feb. 3 to become a Janelia Group Leader! Group Leaders drive breakthroughs & experimental approaches in imaging, molecular engineering, protein chemistry, mass spectrometry, & methods that don't yet exist. Learn more: janelia.org/groupleader 🧪
Lead a lab at Janelia

Pioneer next-generation tools for biological discovery

Apply by Feb. 3, 2026
janelia.org/groupleader
01821
Reposted by Ross Cheloha
James Checco @jameswchecco.bsky.social · 04/12/2025
Consider submitting your peptide research to a special joint issue of JOC and Biochemistry on the Chemistry and Biology of Peptides! axial.acs.org/biology-and-...
axial.acs.org
Call For Papers: Chemistry and Biology of Peptides | ACS Publications Chemistry Blog
This Special Issue will celebrate the chemistry and biology of peptides, from synthesis, to structure and modifications, to biology and applications, and finally to degradation. Submit your manuscript...
092
Reposted by Ross Cheloha
PLOS Biology @plosbiology.org · 25/11/2025
Bitopic ligands comprise a #pharmacophore & a linked moiety that bind to separate sites. @rche54.bsky.social &co show that #GPCRs that bind small molecules can be potently activated by #bitopic #nanobody -ligand conjugates to selectively target pairs of GPCRs @plosbiology.org 🧪 plos.io/4p3VOyH
Proposed mechanism of receptor-dependent activity of bitopic ligands. Structures of PTHR1 and A2AR used in this panel were generated using Alphafold2.
033
Ross Cheloha @rche54.bsky.social · 22/11/2025
It’s really meaningful to have such insightful coverage from a leader in the field @zenbrainest.bsky.social and Xianglin Huang. We appreciate the time they took to write up this very nice commentary!
022
Ross Cheloha @rche54.bsky.social · 22/11/2025
So cool to read this commentary that covers our recent work! journals.plos.org/plosbiology/...
journals.plos.org
Nanobody-drug conjugates for targeting specific GPCR pairs
Bitopic ligands that engage two distinct binding sites offer exciting opportunities for finely tuned control of G protein-coupled receptor signaling. This Primer explores a recent study in PLOS Biology that reports novel nanobody-small molecule conjugates and demonstrates their logic-gated activity at co-expressed receptor pairs with improved signaling profiles.
141
Ross Cheloha @rche54.bsky.social · 22/11/2025
Thanks Anirban! Glad to see this work released
000
Ross Cheloha @rche54.bsky.social · 20/11/2025
#chembio 🧪
000
Ross Cheloha @rche54.bsky.social · 20/11/2025
ii. Recognition that these nanobody-ligand conjugated only show activity when both the nanobody AND ligand targets are expressed (logic gated signaling). This should be useful for delivering molecules with widely expressed targets only to cells of choice! Congrats to Shivani Sachdev and Swarnali Roy
130
Ross Cheloha @rche54.bsky.social · 20/11/2025
This work described for the first time two new directions we are excited to explore: I. nanobody-small molecule conjugates as a sort of analogue of traditional antibody-drug conjugates but we are targeting GPCRs at the cell surface instead of intracellular targets.
110
Ross Cheloha @rche54.bsky.social · 20/11/2025
So pleased to share the final version of this work published in @plosbiology.org ! journals.plos.org/plosbiology/...
journals.plos.org
Development of bitopic nanobody-ligand conjugates targeting G protein-coupled receptors and exhibiting logic-gated signaling
Bitopic ligands are comprised of a pharmacophore and a linked moiety that bind to separate sites. This study shows that G-protein coupled receptors (GPCRs) that bind small molecules can be potently ac...
283
Ross Cheloha @rche54.bsky.social · 03/09/2025
Read this in a paper and it was totally new to me (after 18 years in biochemistry research): “Peptides translated from the sense and antisense strands of DNA interact specifically, analogous to the complementary interactions between DNA double strands.” Is this widely studied/actually true?? 🤯
120
Reposted by Ross Cheloha
Jeremy Baskin @jeremybaskin.bsky.social · 25/08/2025
Faculty opening in Cornell Chemistry at the Assistant Professor level in the area of chemical biology, broadly defined! academicjobsonline.org/ajo/jobs/30338 #chemjobs
academicjobsonline.org
Cornell University, Chemistry and Chemical Biology
Job #AJO30338, WDR-00054776 Assistant Professor - Chemistry and Chemical Biology, Cornell University (Ithaca, NY), Chemistry and Chemical Biology, Cornell University, Ithaca, New York, US
14952
Reposted by Ross Cheloha
Fanny Chasseloup @fannychasseloup.bsky.social · 17/07/2025
Last day at #ENDO2025 was great! Amazing symposium on bone and calcium disorders 🦴 by @rche54.bsky.social @MichailLionakis @MichaelMannstadt with great talks on GPCRs and nanobodies, JAK inhibitors in APECED syndrome & new PTH therapies 🤩
041
Reposted by Ross Cheloha
James Checco @jameswchecco.bsky.social · 23/06/2025
This Wednesday and Thursday is the VIRTUAL Nebraska Drug Discovery and Development Pipeline Symposium! Registration is still open! Plenary speakers include Brian Kobilka and Virginia Man-Yee Lee. #chemsky, you should attend! research.unl.edu/blog/annual-...
research.unl.edu
Annual Nebraska Drug Discovery and Development Pipeline symposium June 25-26
World-renowned experts will offer their insights during the fifth annual ND3P Symposium, set for June 25-26. The symposium will be virtual and highly interactive.
031
Ross Cheloha @rche54.bsky.social · 22/05/2025
Check out the final published product in Journal of Biological Chemistry! www.jbc.org/article/S002...
jbc.org
Evaluation of Alphafold modeling for elucidation of nanobody-peptide epitope interactions
Models of Ab-antigen complexes can be used to understand interaction mechanisms and for improving affinity. This study evaluates the use of the protein structure prediction algorithm AlphaFold (AF) fo...
010
Reposted by Ross Cheloha
George Burslem @gburslem.bsky.social · 01/05/2025
Excited to see this out in @science.org today!! www.science.org/doi/10.1126/...
science.org
Intracellular protein editing enables incorporation of noncanonical residues in endogenous proteins
The ability to study proteins in their native cellular context is crucial to our understanding of biology. In this work, we report a technology for intracellular protein editing, drawing from split in...
613552
Reposted by Ross Cheloha
Freddy E Escorcia, MD/PhD @freddyeescorcia.bsky.social · 14/04/2025
Next up, a collaboration with Ross Cheloha's group (@rche54 @rche54.bsky.social) and @MitchellHo leveraging a novel self-labeling approach for site-specific modification of nanobodies for biological applications. doi.org/10.1002/advs... 3/5
111
Reposted by Ross Cheloha
Freddy E Escorcia, MD/PhD @freddyeescorcia.bsky.social · 14/04/2025
It's been a while since I posted on some of the ☢️ #radiopharmaceuticals ☢️ work we've been brewing. Let's fix that... 🧵👇 1/5
141
Reposted by Ross Cheloha
Jordan Meier @doc-jlmeier.bsky.social · 10/04/2025
Great news: NIH postbac program is recruiting again! If your grad school plans were affected by program cutbacks or admissions freezes this year I highly encourage you to apply, this could be a perfect opportunity. Please repost. www.training.nih.gov/research-tra...
training.nih.gov
6207195
Reposted by Ross Cheloha
Carolyn Bertozzi @carolynbertozzi.bskyverified.social · 26/03/2025
Check out our new review on induced proximity modalities (#TPD and a lot more!) aimed cell surface targets @naturebiotech.bsky.social, spearheaded by postdocs Nick Till and "Rahm" Ramanathan www.nature.com/articles/s41...
nature.com
Induced proximity at the cell surface - Nature Biotechnology
Technologies to modulate induced proximity at the cell surface advance the manipulation of diverse biological responses.
07922
Reposted by Ross Cheloha
AlphaFold Unofficial @alphafold.bsky.social · 20/03/2025
The findings suggest that optimizing input parameters and refining competition-based modeling approaches may enhance predictive accuracy for antibody-antigen interactions. Intriguing.
021
Ross Cheloha @rche54.bsky.social · 20/03/2025
🧪 #chembio
000
Ross Cheloha @rche54.bsky.social · 20/03/2025
Finally we compared models of nanobody-epitope to nanobody-antigen complexes. In one case Alphafold produced an accurate model with epitope but failed with antigen! This highlights the potential utility of simplifying Alphafold inputs for generating models with improved accuracies (4/4)
120
Ross Cheloha @rche54.bsky.social · 20/03/2025
We further showed that Alphafold could be used in a competition mode to identify peptides that bound nanobody with higher affinity than the wild type epitope peptide. We also used modeling to guide design of a peptide-electrophile conjugate that forms a crosslink with nanobody (3/n)
120
Ross Cheloha @rche54.bsky.social · 20/03/2025
We performed modeling of experimentally characterized nanobody-peptide interactions and found that 4/6 models matched experimental data. We also crystallized a new nanobody-peptide complex and showed good concordance between the x-ray structure (my first listing on the pdb!) (2/n)
100
Ross Cheloha @rche54.bsky.social · 20/03/2025
Excited to share a preprint covering a collaborative project from my group, the Bewley lab (NIDDK), and the Pierce lab (University of Maryland) describing our first foray into assessing Alphafold for predicting peptide-nanobody interactions (1/n) www.biorxiv.org/content/10.1...
biorxiv.org
Evaluation of Alphafold modeling for elucidation of nanobody-peptide epitope interactions
Models of Ab-antigen complexes can be used to understand interaction mechanisms and to improve affinity. This study evaluates the use of the protein structure prediction algorithm AlphaFold (AF) for e...
2121
Ross Cheloha @rche54.bsky.social · 13/03/2025
We’re excited to apply this for cell-type specific targeting of gpcrs! Congrats to postdocs Shivani Sachdev and Swarnali Roy on the great work (3/3)
010
Ross Cheloha @rche54.bsky.social · 13/03/2025
We also show that the activity of these conjugates is dependent on nanobody binding. This property allows us to make conjugates that act in an “and” logic gated manner-only active if 2 different targets are coexpressed on on a single cell. (2/n)
120
Ross Cheloha @rche54.bsky.social · 13/03/2025
Proud to share this work from my group in the intramural research program at NIH! We describe a new kind of conjugate made from a small molecule adenosine analog linked to a GPCR targeting nanobody to make antibody drug conjugates that potently and specifically activate signaling (1/n) 🧪 #chembio
1215
Reposted by Ross Cheloha
bioRxivpreprint @biorxivpreprint.bsky.social · 12/03/2025
Nanobody-based conjugates targeting small molecule-binding GPCRs and exhibiting logic-gated signaling www.biorxiv.org/content/10.1101/202…
021
Ross Cheloha @rche54.bsky.social · 27/02/2025
One good thing I saw today
Big gulp 1 gallon drink bag. Big ole plastic bag with a red lid
010
Ross Cheloha @rche54.bsky.social · 23/02/2025
This work was made possible through contributions from experts in multiple fields (chemistry, cancer imaging, antibody discovery) working together! The methods described may be useful for the development of imaging probes to provide diagnostic info on other types of tumors or other diseases (3/3)
020
Ross Cheloha @rche54.bsky.social · 23/02/2025
The ability to visualize tumors enables an assessment of whether treatments are working or whether cancer has spread. This imaging requires probes that specifically label cancer cells. We developed a new chemistry for creating probes that label liver cancer tumors. (2/n)
100
Ross Cheloha @rche54.bsky.social · 23/02/2025
Proud to share this publication about the development of a new method for visualizing tumors! This work resulted from a close collaboration among 3 groups. (1/n) 🧪@freddyeescorcia.bsky.social advanced.onlinelibrary.wiley.com/doi/10.1002/...
advanced.onlinelibrary.wiley.com
Generation of Site‐Specifically Labeled Affinity Reagents via Use of a Self‐Labeling Single Domain Antibody
Several methods have been used to label antibodies to facilitate visualization of cognate targets. Here, we leverage a new variety of conjugation chemistry, based on a crosslinking nanobody, to label...
140
Ross Cheloha @rche54.bsky.social · 16/01/2025
I'm actually related to him (second cousins or so)! Can definitely ID the 90's Huskers fans by their reaction when I share this connection
020
Reposted by Ross Cheloha
Matt Hall @cispt2.bsky.social · 15/01/2025
Our NCATS research program has a history of collaborating and partnering to get treatments to patients. One of my first goals as SD was to capture and share our success in one place - and here it is! 4 approvals and 56 INDs to date - not bad for 12 years old! ncats.nih.gov/research/our...
163
Reposted by Ross Cheloha
Jeremy Baskin @jeremybaskin.bsky.social · 14/01/2025
Overjoyed and honestly relieved to share a Chem Rev magnum opus from Brian Chen & Julia Li titled Synthetic Lipid Biology! In it, we organize efforts across numerous fields to create, manipulate, and analyze lipids and biomembranes. Check it out! doi.org/10.1021/acs.... #lipidtime #chemsky #chembio
table of contents graphic for review titled synthetic lipid biologyabstract of review articlePo-Hsun Brian ChenXiang-Ling (Julia) Li
88825
Reposted by Ross Cheloha
Olalla Vázquez @olallalab.bsky.social · 26/12/2024
🎄Xmas gift!🎁Joint work with #OliverHantschel in @naturecomms.bsky.social 💥! Huge kudos 💪🏼😻 Nina 👩‍🔬 for leading as 1st author & Frank 👨🏼‍🔬 for training her like a pro❤️ Small delay😅 -my👵broke her hip🤦🏼‍♀️-loved ones always come first❤️surgery went good💪🏼🤩Let's celebrate🥳🥂! #ChemBio www.nature.com/articles/s41...
nature.com
Development of mirror-image monobodies targeting the oncogenic BCR::ABL1 kinase - Nature Communications
In this work, the authors develop mirror-image monobodies (Mb) made of D-amino acids against the BCR::ABL1 SH2 domain with high binding affinities. The heterochiral Mb-SH2 structures reveal an unusual...
0306
Reposted by Ross Cheloha
Possu Huang Lab @possuhuanglab.bsky.social · 17/12/2024
1/ In two back-to-back papers, we present our de novo TRACeR platform for targeting MHC-I and MHC-II antigens TRACeR for MHC-I: go.nature.com/4gcLzn5 TRACeR for MHC-II: go.nature.com/4gj5OQk
29129
Ross Cheloha @rche54.bsky.social · 14/12/2024
I think antimicrobial peptides would even work fine (don't act via a membrane receptor): pubs.acs.org/doi/10.1021/... Mostly, the immune system would lose nucleic acid sensing TLR responses and the T cell branch of adaptive immunity (and perhaps B cell/antibody maturation from T cell co-stim)
pubs.acs.org
Retention of Native Quaternary Structure in Racemic Melittin Crystals
Racemic crystallography has been used to elucidate the secondary and tertiary structures of peptides and small proteins that are recalcitrant to conventional crystallization. It is unclear, however, w...
020
Ross Cheloha @rche54.bsky.social · 12/12/2024
A thought provoking scenario: what would happen if "mirror" (reverse chirality) microbe were created and released? The time estimate (10 years) seems long to me as there's been incredible progress in making mirror enzymes. You don't need much of a few mirror enzymes for a self sustaining cascade..🧪
science.org
Confronting risks of mirror life
Broad discussion is needed to chart a path forward.
030